RUNX3 and leukemia: This association supports the notion that the AML1 cluster refers to an immature immunophenotype, while the AML2 cluster characterizes leukemia cells with the expression of maturation markers, i.e., AML1 cells may derive from a pluripotent stem cell and AML2 from a progenitor cell, respectively.